Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
Jun Wang, Prasanti Kotagiri, Paul A Lyons, Federica Mescia, Laura Bergamaschi, Lorinda Turner, Rafia S Al-Lamki, Michael D Morgan, Fernando J Calero-Nieto, Karsten Bach, Nicole Mende, Nicola K Wilson, Emily R Watts, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Patrick F Chinnery, Nathalie Kingston, Sofia Papadia, Kathleen Stirrups, Neil Walker, View ORCID ProfileRavindra K Gupta, Mark Toshner, Michael P Weekes, James A Nathan, View ORCID ProfileSarah R Walmsley, Willem H Ouwehand, Mary Kasanicki, Berthold Göttgens, John C Marioni, Kenneth GC Smith, Jordan S Pober, John R Bradley
doi: https://doi.org/10.1101/2021.01.14.21249801
Jun Wang
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
Prasanti Kotagiri
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Paul A Lyons
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Federica Mescia
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Laura Bergamaschi
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Lorinda Turner
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Rafia S Al-Lamki
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
3Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Michael D Morgan
5Cancer Research UK – Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK
12Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
Fernando J Calero-Nieto
6Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, Cambridgeshire, England CB2 0AW, UK
Karsten Bach
5Cancer Research UK – Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK
7Department of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK
Nicole Mende
6Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, Cambridgeshire, England CB2 0AW, UK
Nicola K Wilson
6Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, Cambridgeshire, England CB2 0AW, UK
Emily R Watts
8Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, EH16 4TJ, UK
Patrick F Chinnery
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
10Department of Clinical Neurosciences, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
11Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0XY, UK
Nathalie Kingston
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
12Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
Sofia Papadia
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
13Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
Kathleen Stirrups
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
12Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
PhDNeil Walker
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
12Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
Ravindra K Gupta
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Mark Toshner
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
14Royal Papworth Hospital NHS Foundation Trust, Papworth Road, Cambridge CB2 0AY, UK
Michael P Weekes
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
James A Nathan
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Sarah R Walmsley
8Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, EH16 4TJ, UK
Willem H Ouwehand
6Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, Cambridgeshire, England CB2 0AW, UK
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
15NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, CB2 0PT, UK
Mary Kasanicki
3Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
Berthold Göttgens
6Department of Haematology, Wellcome & MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, Cambridgeshire, England CB2 0AW, UK
John C Marioni
4Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK
5Cancer Research UK – Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK
16EMBL-EBI, Wellcome Genome Campus, Hinxton, CB10 1SD, UK
Kenneth GC Smith
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
2Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK
Jordan S Pober
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
17Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, CT 06519, USA
John R Bradley
1Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, CB2 0QQ, UK
3Cambridge University Hospitals NHS Foundation Trust, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
9NIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
Data Availability
The NIHR BioResource makes data available to researchers through a Data Access Application process described at: https://bioresource.nihr.ac.uk/using-our-bioresource/academic-and-clinical-researchers/apply-for-bioresource-data/
Posted January 15, 2021.
Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
Jun Wang, Prasanti Kotagiri, Paul A Lyons, Federica Mescia, Laura Bergamaschi, Lorinda Turner, Rafia S Al-Lamki, Michael D Morgan, Fernando J Calero-Nieto, Karsten Bach, Nicole Mende, Nicola K Wilson, Emily R Watts, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Patrick F Chinnery, Nathalie Kingston, Sofia Papadia, Kathleen Stirrups, Neil Walker, Ravindra K Gupta, Mark Toshner, Michael P Weekes, James A Nathan, Sarah R Walmsley, Willem H Ouwehand, Mary Kasanicki, Berthold Göttgens, John C Marioni, Kenneth GC Smith, Jordan S Pober, John R Bradley
medRxiv 2021.01.14.21249801; doi: https://doi.org/10.1101/2021.01.14.21249801
Factor V is an immune inhibitor that is expressed at increased levels in leukocytes of patients with severe Covid-19
Jun Wang, Prasanti Kotagiri, Paul A Lyons, Federica Mescia, Laura Bergamaschi, Lorinda Turner, Rafia S Al-Lamki, Michael D Morgan, Fernando J Calero-Nieto, Karsten Bach, Nicole Mende, Nicola K Wilson, Emily R Watts, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Patrick F Chinnery, Nathalie Kingston, Sofia Papadia, Kathleen Stirrups, Neil Walker, Ravindra K Gupta, Mark Toshner, Michael P Weekes, James A Nathan, Sarah R Walmsley, Willem H Ouwehand, Mary Kasanicki, Berthold Göttgens, John C Marioni, Kenneth GC Smith, Jordan S Pober, John R Bradley
medRxiv 2021.01.14.21249801; doi: https://doi.org/10.1101/2021.01.14.21249801
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)